Search - tctmd.com

Displaying 1 - 20 of 47

Sort: Relevancy | Date

News Features

Funding the Future: How Industry Support for CV Trials Could Evolve

Michael O'Riordan

December 17, 2020

Next-Gen MitraClip Performs as Well as Earlier Device in COAPT: EXPAND

Michael O'Riordan

November 25, 2020

News Daily News

Lotus Edge TAVR Device Recalled and Discontinued Worldwide

Michael O'Riordan

November 18, 2020

News Daily News

US TAVR Cases Pass a Quarter Million, Surpassing Surgery: Key Trends

Caitlin E. Cox

November 17, 2020

News Industry News

Corvia Medical Completes Randomization In Reduce Lap-Hf II Pivotal Trial And Gains Fda Authorization To Provide Continued Access For The Corvia Atrial Shunt

November 17, 2020

News Conference News AHA 2020

EARLY-AF: First-line Ablation Beats Meds for Recent Paroxysmal A-fib

Shelley Wood

November 16, 2020

News Daily News

CMS Weighs Medicare Coverage at the Time of FDA Approval for Breakthrough Devices

Michael O'Riordan

October 30, 2020

News Industry News

Medtronic Venous Stent Recieves U.S. FDA Approval to Treat Venous Outflow Obstruction

October 26, 2020

News Conference News TCT 2020

Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up

Michael O'Riordan

October 23, 2020

News Conference News TCT 2020

Trickier Patients, Fewer Adverse Events in High-risk PCI: Impella PROTECT III Registry

Caitlin E. Cox

October 18, 2020

News Conference News TCT 2020

OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES

L.A. McKeown

October 17, 2020

Presentation TCT 2020

Regulatory Viewpoints on MCS Device Approval

Presenter: Meir Shinnar

October 16, 2020

News Conference News TCT 2020

Global EXPAND: Next-Gen MitraClip Cuts MR, Boosts QoL at 1 Year

L.A. McKeown

October 16, 2020

Presentation TCT 2020

Industry Sponsors (Supporting Innovation and Medical Device Approval)

Presenter: Manuela Negoita

October 15, 2020

News Conference News TCT 2020

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

Todd Neale

October 15, 2020

News Opinion Editor's Corner TCT 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Shelley Wood

October 09, 2020

In-Stent Restenosis Accounts for 10% of All PCIs, Contemporary National Analysis Shows

News Daily News

In-Stent Restenosis Accounts for 10% of All PCIs, National Analysis Shows

L.A. McKeown

September 24, 2020

News Daily News

Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years

L.A. McKeown

September 17, 2020

News Conference News ESC 2020

Implantation Technique Influences LV Remodeling After TMVR

Todd Neale

September 04, 2020

News Industry News

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

September 02, 2020

Advertisement

Funding the Future: How Industry Support for CV Trials Could Evolve

Next-Gen MitraClip Performs as Well as Earlier Device in COAPT: EXPAND

Lotus Edge TAVR Device Recalled and Discontinued Worldwide

US TAVR Cases Pass a Quarter Million, Surpassing Surgery: Key Trends

Corvia Medical Completes Randomization In Reduce Lap-Hf II Pivotal Trial And Gains Fda Authorization To Provide Continued Access For The Corvia Atrial Shunt

EARLY-AF: First-line Ablation Beats Meds for Recent Paroxysmal A-fib

CMS Weighs Medicare Coverage at the Time of FDA Approval for Breakthrough Devices

Medtronic Venous Stent Recieves U.S. FDA Approval to Treat Venous Outflow Obstruction

Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up

Trickier Patients, Fewer Adverse Events in High-risk PCI: Impella PROTECT III Registry

OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES

Regulatory Viewpoints on MCS Device Approval

Global EXPAND: Next-Gen MitraClip Cuts MR, Boosts QoL at 1 Year

Industry Sponsors (Supporting Innovation and Medical Device Approval)

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

In-Stent Restenosis Accounts for 10% of All PCIs, National Analysis Shows

Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years

Implantation Technique Influences LV Remodeling After TMVR

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content